DDN July 2017 DDN July2017 | Page 14

MDMA HEIGHT OF ecstasy Summer brings the festivals – and a new young crowd experimenting with MDMA. Kevin Flemen gives the guide to staying safe ‘W ho is Leah Betts?’ The question, from a recently qualified social worker on an NPS course, brought home to me some important issues. Leah died in 1995, aged 18, after using MDMA and drinking a large quantity of water. Campaigns by her family, the media and advertising agencies saw her posthumously become the ‘poster girl’ for the dangers of MDMA. That was 1995, and my newly-qualified social worker was a baby when this happened. She and a whole cohort of children and young adults have not grown up in the shadow of Leah’s death. They didn’t read about it in the papers, see the video at school or learn about it from earnest drug educators. This matters now more than ever. This MDMA-naïve generation are going out at a time when MDMA pills have never been as strong, cheap, or widely available. Alongside the pills containing dangerous adulterants, powder and crystal MDMA may also be adulterated or misidentified. Alongside the Leah question, I hear another: ‘Frank – is that still going?’ The days when the drugs helpline enjoyed TV adverts and a budget allowing for innovative cross-platform promotion are long gone. It became a casualty of cuts along with the club outreach that helped reduce the risks to a generation of young people. So with exams coming to an end and the festival season underway, it is imperative that those MDMA harm reduction messages are dusted off, refreshed and communicated to the new generation of users. As ever, drug terms and slang vary from place to place and over time. The drug MDMA is variously known as Mandy, Molly, ecstasy, E and XTC and some young people may not be aware of its ‘proper’ name. Terms may link to form (‘ecstasy’ had referred primarily to pills, MDMA to powder and crystals) but this isn’t always the case. Pill strength has increased significantly over the past couple of years and has become a key concern. There is no routine, consistent monitoring of available pill strengths in the UK, so comparisons are partly estimates. Back in the late ’80s and early ’90s, MDMA pills contained around 80mg per pill and would retail for £5-10. Looking at the range of pills currently available on dark web sites such as Dream Market, there are a few at the 160mg mark but most claim strength of between 220mg and 250mg, so average pill strength has probably trebled. New production methods and the massive marketplace that is the dark web have seen manufacturers competing on strength and price, so low cost is no longer 14 | drinkanddrugsnews | July/August 2017 indicative of a low-dosed pill. For older users accustomed to swallowing two or three pills at a time, or for younger users with no tolerance, these high dose pills can cause fatal overdoses. Crystal contamination Just as pills can vary significantly in terms of dose and composition, the same is true for products sold as powder or crystal MDMA. Alternative substances or adulterants may be present and whereas one can check online for pill warnings, powders and crystals are harder to identify visually. Looking at submissions to the Welsh testing site WEDINOS, samples bought as powder or crystal MDMA contained a range of compounds including previously legal NPS such as methylone, mephedrone and a-PVP, alongside cocaine, caffeine, speed and a host of other compounds. There is no easy way for end users to assess pill strength, or the content of powders and crystals. The claimed strength of dark web retailers cannot be relied on, and as fast as ‘genuine’ pills are sold online, fake ones are likely to appear on the streets. Other options for information include Erowid’s Ecstasy Data (www.ecstasydata.org) the user-run Pill Report (pillreports.net) and WEDINOS, (www.wedinos.org) from Public Health Wales. Each carries useful information on components or user experience, but little on pill strengths. Thanks to the efforts of The Loop (wearetheloop.org), club and festival pill testing has increased, and at a small but growing number of events it is now possible to have drugs tested and results passed back to users and health professionals in a short timeframe. www.drinkanddrugsnews.com